Natera Integrates with Flatiron Health’s OncoEMR® Platform
Streamlined digital entry now out there for Natera’s scientific oncology portfolio throughout Flatiron Health’s community of 4,500+ most cancers care suppliers Natera, Inc. (NASDAQ: NTRA), a world chief in cell-free DNA and precision medication, and Flatiron Health, a number one healthtech firm devoted to increasing the probabilities of point-of-care options in oncology, as we speak introduced the…
